Exhibit 10.3 


 


NON-STATUTORY STOCK OPTION

(Definitive/Contingent – Employees)


 


Granted by


 


Cellectar Biosciences, Inc.(the “Company”)


 


Under the 2015 Stock Incentive Plan (as
amended and restated)


 


This Option is and shall be subject in every
respect to the provisions of the Company’s 2015 Stock Incentive Plan, as amended from time to time, which is incorporated
herein by reference and made a part hereof. The holder of this Option (the “Holder”) hereby accepts this Option subject
to all the terms and provisions of the Plan and agrees that (a) in the event of any conflict between the terms hereof and those
of the Plan, the latter shall prevail, and (b) all decisions under and interpretations of the Plan by the Board or the Committee
shall be final, binding and conclusive upon the Holder and his or her heirs and legal representatives.


 


		1.	Name of Holder:



 


		2.	Date of Grant:



 


		3.	Maximum Number of Shares for which this Option is
exercisable:



 


Definitive Grant:


 


Contingent
Grant:


 


		4.	Exercise (purchase) price per share: $



 


		5.	Payment method: 



 


a personal, certified or bank
check or postal money order payable to the order of the Company for an amount equal to the exercise price of the shares being purchased;
or


 


with the consent of the Company,
any of the other methods set forth in the Plan.


 


		6.	Expiration Date of Option: 



 


		7.	Vesting Schedule:  The Definitive Grant shall vest as to all shares on the first
anniversary of the Date of Grant. The Contingent Grant shall vest subject to the following conditions: (i) approval by the Company’s
stockholders of an increase in shares available under the 2015 Stock Incentive Plan at the Company’s 2019 annual meeting
of stockholders or other special meeting of stockholders called for such purpose (the “Stockholder Approval”); and
(ii) to the extent the Stockholder Approval is received, the Contingent Grant shall vest over a period of three years from the
Date of Grant, vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the Date of
Grant.



 






     


     


    

 


Notwithstanding the foregoing, and with respect to
the Contingent Grant subject to the issuance of such Contingent Grant upon obtaining the Stockholder Approval, the vesting of this
Option shall accelerate with respect to all of the then unvested shares upon a Termination Event.


 


As used herein, a “Termination Event”
shall mean either of the following events, but only if such event occurs within one year of a “Change of Control” (as
defined in the Plan):


 


(i) termination
by the Company of the Holder’s employment or service relationship with the Company for any reason other than for “Cause,”
as defined in the Plan; or


 


(ii) the
Holder’s resignation as an employee of, or service provider to, the Company , other than for reasons of Disability (as defined
in the Plan), following (x) a significant reduction in the nature or scope of the Holder’s duties, responsibilities, authority
or powers, from the duties, responsibilities, authority or powers exercised by the Holder immediately prior to the Change of Control,
or (y) a reduction in the Holder’s annual base salary (or base fees, as applicable) or benefits as in effect on the date
of the Change of Control, except for across-the-board salary or benefits reductions affecting all similarly situated personnel
of the Company, or (z) a transfer of the Holder from the office of the Company where he is based immediately before the Change
of Control to an office more than twenty-five (25) miles away such office (unless the distance the Holder has to travel to work
is actually shortened as a result of such transfer).


 


For purposes of this Section 7,
“Company” shall include any surviving entity, in the case of a merger or acquisition in which the Company is not the
surviving entity.


 


		8.	Termination of Employment or Provision of Services. This Option shall terminate on the earliest to occur of:



 


		(i)	the date of expiration thereof;



 


		(ii)	immediately upon termination of the Holder’s employment with, or provision of services to, the Company by the Company
for Cause (as defined in the Plan);



 


		(iii)	thirty (30) days after the date of voluntary termination of employment or provision of services by the Holder (other than upon
death, or for Disability or Normal Retirement, each as defined in the Plan);



 


		(iv)	ninety (90) days after the date of involuntary termination of the Holder’s employment with, or provision of services
to, the Company by the Company without Cause (as defined in the Plan), or termination of the Holder’s employment or provision
of services by reason of Disability or Normal Retirement (each as defined in the Plan); or



 


		(v)	180 days after the date of termination of the Holder’s employment with, or provision of services to, the Company by reason
of death.



 






    2 


     


    

 


		9.	Lock-Up Agreement.  The Holder agrees for a period of up to 180 days from the effective date of any registration of
securities of the Company under the Securities Act of 1933, as amended (the “Securities Act”), upon request of the
Company or underwriters managing any underwritten offering of the Company’s securities, not to sell, make any short sale
of, loan, grant any option for the purchase of, or otherwise dispose of any shares issued pursuant to the exercise of this Option,
without the prior written consent of the Company and such underwriters.



 


		10.	Tax Withholding. The Company’s obligation to deliver shares shall be subject to the Holder’s satisfaction
of any federal, state and local income and employment tax withholding requirements.



 


		11.	Notice.  Any notice to be given to the Company hereunder shall be deemed sufficient if addressed to the Company and
delivered to the office of the Company, 100 Campus Drive, Florham Park, NJ 07932, attention of the president, or such other address
as the Company may hereafter designate.



 


Any notice to be given to the Holder
hereunder shall be deemed sufficient if addressed to and delivered in person to the Holder at his or her address furnished to the
Company or when deposited in the mail, postage prepaid, addressed to the Holder at such address.





 


IN WITNESS WHEREOF, the parties have executed
this Option, or caused this Option to be executed, as of the Date of Grant.


 





	 	CELLECTAR BIOSCIENCES, INC.
	 	 	 
	 	By: 	                          




 


The undersigned Holder hereby acknowledges receipt of a copy
of the Plan and this Option, and agrees to the terms of this Option and the Plan.


 


 





	 	 
	Holder	 





 








    3